Clinical research data sharing: What an open science world means for researchers involved in evidence synthesis

Systematic Reviews

Volumn 5, Issue 1, 2016, Pages

  Ross, Joseph S ^a,b,c  

^a ROBERT WOOD JOHNSON FOUNDATION   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Clinical trials; Data sharing; Systematic reviews

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; INFORMATION SERVICE; MOLECULAR LIBRARY; PRIORITY JOURNAL; PUBLICATION; STUDY DESIGN; CLINICAL TRIAL (TOPIC); HUMAN; INFORMATION DISSEMINATION; MEDICAL RESEARCH; PERSONNEL; PROCEDURES; PUBLISHING;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; EDITORIAL POLICIES; HUMANS; INFORMATION DISSEMINATION; PUBLICATIONS; RESEARCH PERSONNEL;

EID: 84988600769     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-016-0334-1     Document Type: Article

References (38)

1. Taichman DB, Backus J, Baethge C, Bauchner H, de Leeuw PW, Drazen JM, Fletcher J, Frizelle FA, Groves T, Haileamlak A, et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Ann Intern Med. 2016;164:505-6.
2. Comments on the ICMJE's proposals for sharing clinical trial data. [ http://icmje.org/news-and-editorials/sharing_clinical_trial_data_comments_feed.html ]. Accessed 14 July 2016.
3. Ross JS, Krumholz HM. Ushering in a new era of open science through data sharing: the wall must come down. JAMA. 2013;309:1355-6.
4. Hudson KL, Collins FS. Sharing and reporting the results of clinical trials. JAMA. 2015;313:355-6.
5. Principles for responsible clinical trial data sharing. Our commitment to patients and researchers. [ http://phrma.org/sites/default/files/pdf/PhRMAPrinciplesForResponsibleClinicalTrialDataSharing.pdf ]. Accessed 14 July 2016.
6. Krumholz HM, Gross CP, Blount KL, Ritchie JD, Hodshon B, Lehman R, Ross JS. Sea change in open science and data sharing: leadership by industry. Circ Cardiovasc Qual Outcomes. 2014;7:499-504.
7. Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM, Strait KM, Ross JS. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ. 2012;345:e7570.
8. Tenopir C, Allard S, Douglass K, Aydinoglu AU, Wu L, Read E, Manoff M, Frame M. Data sharing by scientists: practices and perceptions. PLoS One. 2011;6:e21101.
9. Tenopir C, Dalton ED, Allard S, Frame M, Pjesivac I, Birch B, Pollock D, Dorsett K. Changes in data sharing and data reuse practices and perceptions among scientists worldwide. PLoS One. 2015;10:e0134826.
10. Institute of Medicine of the National Academies of Science. Sharing clinical trial data: maximizing benefits, minimizing risks. Washington, DC: National Academies Press; 2015.
11. Ross JS, Gross CP, Krumholz HM. Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health. 2012;102:72-80.
12. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e3081.
13. Dwan K, Altman DG, Clarke M, Gamble C, Higgins JP, Sterne JA, Williamson PR, Kirkham JJ. Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med. 2014;11:e1001666.
14. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-72.
15. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med. 2009;6:e1000144.
16. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012;344:d7292.
17. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-60.
18. Chen R, Desai NR, Ross JS, Zhang W, Chau KH, Wayda B, Murugiah K, Lu DY, Mittal A, Krumholz HM. Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. BMJ. 2016;352:i637.
19. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: recommendations from the Tamiflu experience. PLoS Med. 2012;9:e1001201.
20. Wieseler B, Wolfram N, McGauran N, Kerekes MF, Vervolgyi V, Kohlepp P, Kamphuis M, Grouven U. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLoS Med. 2013;10:e1001526.
21. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med. 2009;169:1756-61.
22. DRYAD. [ http://datadryad.org/ ]. Accessed 14 July 2016.
23. Yale University Open Data Access Project. [ http://yoda.yale.edu/ ]. Accessed 14 July 2016.
24. ClinicalStudyDataRequest.com. [ https://www.clinicalstudydatarequest.com/ ]. Accessed 14 July 2016.
25. Becker JE, Krumholz HM, Ben-Josef G, Ross JS. Reporting of results in ClinicalTrials.gov and high-impact journals. JAMA. 2014;311:1063-5.
26. Hartung DM, Zarin DA, Guise JM, McDonagh M, Paynter R, Helfand M. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med. 2014;160:477-83.
27. Press release: Cochrane Collaboration statement on access to clinical trial data. [ http://www.cochrane.org/features/clinical-trials-statement-press-release ]. Accessed 14 July 2016.
28. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292:1363-4.
29. Boccia S, Rothman KJ, Panic N, Flacco ME, Rosso A, Pastorino R, Manzoli L, La Vecchia C, Villari P, Boffetta P, et al. Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. J Clin Epidemiol. 2016;70:176-82.
30. Dal-Re R, Ross JS, Marusic A. Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reporting. J Clin Epidemiol. 2016;75:100-7.
31. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med. 2011;364:852-60.
32. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353:2779-87.
33. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2.
34. Tricco AC, Cogo E, Page MJ, Polisena J, Booth A, Dwan K, MacDonald H, Clifford TJ, Stewart LA, Straus SE, Moher D. A third of systematic reviews changed or did not specify the primary outcome: a PROSPERO register study. J Clin Epidemiol 2016: doi: 30010.31016/j.jclinepi.32016.30003.30025. [Epub ahead of print].
35. Welcome to PROSPERO, international prospective register of systematic reviews. [ http://www.crd.york.ac.uk/PROSPERO/ ]. Accessed 14 July 2016.
36. Laine C, De Angelis C, Delamothe T, Drazen JM, Frizelle FA, Haug C, Hebert PC, Horton R, Kotzin S, Marusic A, et al. Clinical trial registration: looking back and moving ahead. Ann Intern Med. 2007;147:275-7.
37. Open Science Framework. [ https://osf.io/ ]. Accessed 14 July 2016.
38. Rodwin MA, Abramson JD. Clinical trial data as a public good. JAMA. 2012;308:871-2.